Medicine and Dentistry
2,3,7,8 Tetrachlorodibenzo Para Dioxin
6%
Adult
8%
Adverse Event
6%
Age
15%
Analysis
10%
Association
8%
Beta Chemokine
8%
Bevacizumab
6%
Blood
10%
Breast Reconstruction
6%
Cells
11%
Chemokine Receptor
9%
Child
7%
Clinical Trial
7%
Combination Therapy
18%
Complication
6%
Diabetes Mellitus
7%
Diagnosis
11%
Diseases
7%
Erythrocyte
11%
Experience
7%
Fibromyalgia
13%
Free Tissue Graft
6%
Glioblastoma
6%
Health
8%
Incidence
6%
Injury
28%
Inpatient
22%
Laparoscopy
8%
Macrophage
7%
Malignant Neoplasm
8%
Measurement
8%
Morbidity
6%
Mortality
12%
Muscle Regeneration
8%
Natural Orifice Translumenal Endoscopic Surgery
11%
Neoplasm
18%
Patient
100%
Pediatrics
6%
Platelet
8%
Rhabdomyosarcoma
26%
Sarcoma
6%
Serum
7%
Surgery
13%
Survival
12%
Syndrome
6%
Therapeutic Procedure
27%
Tissues
9%
Veteran
7%
Xenograft
8%
Pharmacology, Toxicology and Pharmaceutical Science
2,3,7,8-Tetrachlorodibenzodioxin
53%
Adverse Event
5%
Agent Orange
18%
Bevacizumab
5%
Chemotherapy
6%
Clinical Trial
5%
Diabetes Mellitus
13%
Dioxins and Dioxin-Like Compounds
34%
Diseases
6%
Elimination
9%
Epidemiology
7%
Fat
11%
Fibromyalgia
11%
Herbicide
30%
Injury
6%
Insulin
6%
Malignant Neoplasm
10%
Mortality
9%
Neoplasm
5%
Pharmacokinetics
6%
Placebo
6%
Pollutant
11%
Prevalence
6%
Rhabdomyosarcoma
8%
Syndrome
7%
Nursing and Health Professions
Combination Therapy
5%
Control
8%
Diabetes Mellitus
6%
Incidence
5%
Injury
7%
Inpatient
6%
Measurement
8%
Oxygen
5%
Patient
24%
Placebo
7%
Procedures
10%
Standard
6%
Time
7%
Wound
5%
